Copper-Heparin Inhalation Therapy To Repair Emphysema: A Scientific Rationale

Current pharmacotherapy of chronic obstructive pulmonary disease (COPD) aims at reducing respiratory symptoms and exacerbation frequency. Effective therapies to reduce disease progression, however, are still lacking. Furthermore, COPD medications showed less favorable effects in emphysema than in ot...

Descripción completa

Detalles Bibliográficos
Autores principales: Janssen, Rob, Wouters, Emiel FM, Janssens, Wim, Daamen, Willeke F, Hagedoorn, Paul, de Wit, Hugo AJM, Serré, Jef, Gayan-Ramirez, Ghislaine, Franssen, Frits ME, Reynaert, Niki L, von der Thüsen, Jan H, Frijlink, Henderik W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884741/
https://www.ncbi.nlm.nih.gov/pubmed/32063701
http://dx.doi.org/10.2147/COPD.S228411

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6884741/
https://www.ncbi.nlm.nih.gov/pubmed/32063701
http://dx.doi.org/10.2147/COPD.S228411

Ejemplares similares